tiprankstipranks
American Oriental Bioengineering Inc (AOBI)
OTHER OTC:AOBI
US Market
Holding AOBI?
Track your performance easily

American Oriental Bioengineering (AOBI) Financial Statements

11 Followers

American Oriental Bioengineering Financial Overview

American Oriental Bioengineering's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; American Oriental Bioengineering is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 13Jun 13Mar 13Dec 12Sep 12
Income Statement-
Total Revenue$ 17.94M$ 20.22M$ 21.01M$ 62.41M$ 29.49M
Gross Profit$ 3.11M$ 4.99M$ 4.50M$ 27.03M$ 6.46M
EBIT$ -18.97M$ -10.32M$ -20.00M$ 4.84M$ -19.20M
EBITDA$ -16.01M$ -7.23M$ -16.96M$ 7.91M$ -16.16M
Net Income Common Stockholders$ -21.18M$ -12.84M$ -21.11M$ -35.89M$ 19.12M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.23M$ 7.00M$ 6.42M$ 7.10M$ 26.43M
Total Assets$ 427.62M$ 418.80M$ 423.73M$ 446.31M$ 501.16M
Total Debt$ 92.77M$ 64.69M$ 62.68M$ 67.64M$ 67.21M
Net Debt$ 89.54M$ 57.68M$ 56.26M$ 60.55M$ 40.78M
Total Liabilities$ 143.95M$ 117.44M$ 116.01M$ 118.72M$ 139.66M
Stockholders Equity$ 283.68M$ 301.37M$ 307.72M$ 327.59M$ 362.03M
Cash Flow-
Free Cash Flow$ -30.80M$ -4.04M$ -2.21M$ -22.61M$ -4.12M
Operating Cash Flow$ -17.05M$ -3.02M$ -1.85M$ -9.31M$ -2.70M
Investing Cash Flow$ -13.27M$ -1.28M$ 3.87M$ -10.63M$ -213.70K
Financing Cash Flow$ 25.86M$ 2.90M$ -1.70M$ 957.64K$ -18.37M
Currency in USD

American Oriental Bioengineering Earnings and Revenue History

American Oriental Bioengineering Debt to Assets

American Oriental Bioengineering Cash Flow

American Oriental Bioengineering Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis